
Hartford HealthCare Cancer Institute/chd-inc.com
Aug 10, 2025, 12:49
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute Has Launched First-in-Human Phase 1A Clinical Trial
Krishna Soujanya Gunturu, Associate Chief, Clinical Trials and Correlative Science Research Hartford Health Cancer Institute at Hartford HealthCare, shared a post on LinkedIn:
“The Hartford HealthCare Cancer Institute has officially launched its first-in-human Phase 1A clinical trial, marking a significant milestone in the advancement of innovative cancer therapies.
We extend our heartfelt congratulations to our incredible team for their dedication, innovation, and tireless efforts in launching Phase 1A clinical trials.
This milestone reflects our unwavering commitment to advancing cancer care and bringing hope to patients through pioneering research.”
More Posts Featuring Krishna Soujanya Gunturu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 10, 2025, 12:46
Aug 10, 2025, 12:39
Aug 10, 2025, 12:29
Aug 10, 2025, 11:31
Aug 10, 2025, 11:24
Aug 10, 2025, 10:19